Grayscale and Canary Capital Introduce SUI ETFs for Direct Token Exposure
TLDR
- Canary Capital launched the Canary Stake SUI ETF on Nasdaq, offering exposure to the SUI token and staking rewards.
- Grayscale converted its SUI trust into an ETF,
» Read more about: Grayscale and Canary Capital Introduce SUI ETFs for Direct Token Exposure »
Read MoreMarch 7 Brings a Social Security Shake-Up Most Americans Will Miss
Quick Read
-
Social Security transitions from local to nationwide customer service on March 7 for appointment scheduling and case distribution.
-
Staffing cuts from the Department of Government Efficiency forced the change after thousands of workers were laid off.
-
Workers expect problems serving customers nationwide because they only know local and state-specific Social Security rules.
» Read more about: March 7 Brings a Social Security Shake-Up Most Americans Will Miss »
Read MoreWall Street: S&P 500, Dow Jones erase losses, banks shine despite AI uncertainty
US stock indices were subdued in volatile trading on Tuesday, following persistent anxieties regarding the future of artificial intelligence (AI) and as market participants redirected their attention toward the US-Iran nuclear negotiations.
The volatility triggered by AI underscores concerns that are becoming notably contradictory.
Dow Jones, S&P 500, Nasdaq open higher amid easing investor concerns over AI; US Fed's minutes release in focus
US stock market today: The benchmark US stock market indices like the Dow Jones, S&P 500, and Nasdaq Composite open higher on Wednesday, 18 February 2026, amid easing investor concerns over artificial intelligence (AI). The investors will also keep their focus on the US Fed’s minutes release, which is scheduled for later today.
Consumer Staples Are Leading With the S&P 500 Near Record Highs. History Says That Rarely Ends Well.
The Burst
Massive Upside In Big Money Pharma Favorite?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes in the use of immune therapies for cancer treatment. Specifically, Iovance is exploring new applications of tumor infiltrating lymphocyte (TIL) therapy, utilizing cells that the human body naturally produces to attack cancerous tumors.
There was lots of hype about this next-generation cancer treatment company but its share price has been decidedly lackluster this year,
» Read more about: Massive Upside In Big Money Pharma Favorite? »
Read MoreThe Ivy
Will This ETF 2x Before Year End?
In recent months, some of the most sophisticated investors on Wall Street have made a bold move by pouring hundreds of millions into BlackRock’s iShares Bitcoin Trust (IBIT).
This isn’t just a passing trade but a conviction bet that Bitcoin’s best days may still be ahead and while still trading under $100,000 per coin,
» Read more about: Will This ETF 2x Before Year End? »
Read MoreThe Spotlight
Why This Beverage Giant Can’t Be Toppled
A famous book on business was titled Barbarians at the Gate, documenting the leveraged buyout of RJR Nabisco. If nothing else, it highlights how just the sniff of an opportunity to make money can drive money seekers to make wild decisions.
Some giant businesses have been on the receiving end of similar threats to their solvency as invaders attempt to take their share.
» Read more about: Why This Beverage Giant Can’t Be Toppled »